1985
DOI: 10.1093/nar/13.3.841
|View full text |Cite
|
Sign up to set email alerts
|

Effect of the tripartite leader on synthesis of a non-viral protein in an adenovirus 5 recombinant

Abstract: The EIa region of an Adenovirus 5 recombinant has been substituted by a modular gene encoding dihydrofolate reductase (DHFR). In this recombinant, the mouse DHFR cDNA was positioned behind sequences of the major late promoter and the complete tripartite leader. The leader sequences end in the normal 5' splice site (SS) of the third leader, so that RNA splicing joins the tripartite leader to a 3' splice site immediately upstream of the DHFR cDNA. At late stages of infection, high levels of DHFR mRNAs were synth… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
63
0

Year Published

1985
1985
2005
2005

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 90 publications
(64 citation statements)
references
References 18 publications
(20 reference statements)
1
63
0
Order By: Relevance
“…19 The higher expression of the HSVtk gene is likely due to vector replication and its preceding by the Ad5 TPL. 20,21 This suggests that the level of HSVtk expression as previously reported 22 and the presence of E1a, independent of its role in adenoviral replication, are not responsible for the significantly enhanced antitumor effect, compared with either treatment used alone, when GCV was given to Ad.TK RC -treated mice after allowing time for viral replication. This observation demonstrates the importance of the amplification and spread of the viral inoculum beyond the initially infected cells by in situ conversion of the originally transduced cells into adenoviral producer cells.…”
Section: Discussionsupporting
confidence: 55%
“…19 The higher expression of the HSVtk gene is likely due to vector replication and its preceding by the Ad5 TPL. 20,21 This suggests that the level of HSVtk expression as previously reported 22 and the presence of E1a, independent of its role in adenoviral replication, are not responsible for the significantly enhanced antitumor effect, compared with either treatment used alone, when GCV was given to Ad.TK RC -treated mice after allowing time for viral replication. This observation demonstrates the importance of the amplification and spread of the viral inoculum beyond the initially infected cells by in situ conversion of the originally transduced cells into adenoviral producer cells.…”
Section: Discussionsupporting
confidence: 55%
“…Consequently, we attempted to produce replication-defective Ad vectors in which the expression of RG was driven by the strong MCMV promoter (Dorsch-Hasler et al, 1985 ;Addison et al, 1997) in combination with an intron sequence previously used in Ad vectors (Berkner & Sharp, 1985). The construction of plasmid pMH5(I)Fx is described in Methods and shown in Fig.…”
Section: Resultsmentioning
confidence: 99%
“…1). The Ad-immunoglobulin hybrid intron from plasmid pMLPsp1a (Kaufman & Sharp, 1982 ;Berkner & Sharp, 1985) was isolated by PCR amplification and inserted into the EcoRI site of pMH5 to generate pMH5(I). The RG gene was cloned into pMH5(I) downstream of the MCMV promoter and the intron to produce plasmid pMH5(I)Fx.…”
Section: Methodsmentioning
confidence: 99%
“…The activity of the parental plasmid, pBLCAT6, was then normalized to 1 in all cell lines. As a positive control, pD5CAT, which contains the SV40 promoter/enhancer region upstream of the CAT gene was used (Berkner and Sharp, 1985, data not shown). The most active Ron/CAT promoter construct in CMT-93 cells had approximately 10% of the amount of CAT protein produced compared to the positive control.…”
Section: Deletion Analyses Of the 5'¯anking Dna Of The Mouse Ron Genementioning
confidence: 99%